The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B
Open accessAbstract
Recent advances in the field of hepatitis B encouraged EASL to organise a consensus conference in order to define the state of knowledge and to elaborate recommendations for the management of patients with hepatitis B. An organising committee drafted questions to be addressed at the conference, developed an agenda and selected the speakers. International experts in the field of virology, epidemiology, natural history,prevention,andthe treatmentofhepatitisBprovided2 days of presentation and discussions. The Jury was asked to weigh the scientific evidence and to prepare a consensus statement addressing the following eight questions. (1) What are the public health implications of hepatitis B? (2) What is the natural history of hepatitis B, what are the factors influencing the disease? (3) What is the best way to diagnose and classify hepatitis B? (4) How can transmission of hepatitis B be prevented? (5) Which patients should be treated? (6) What is the optimal treatment? (7) How should untreated and treated patients be monitored? (8) What are the main unresolved issues?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Cited by
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., Yuen, J. C.-H., Wong, W.-M., Chan, A. O.-O., Wong, B. C.-Y., Lai, K.-C., & Lai, C.-L. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 375
Kew, M. C. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.005 · Cited by 275
Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years
Manno, M., Cammà, C., Schepis, F., Bassi, F., Gelmini, R., Giannini, F., Miselli, F., Grottola, A., Ferretti, I., Vecchi, C., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.021 · Cited by 256
Pavlides, M., Banerjee, R., Sellwood, J., Kelly, C. J., Robson, M. D., Booth, J. C., Collier, J., Neubauer, S., & Barnes, E. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.009 · Cited by 212
Metadata
- Authors
- Jury, T. E.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 39
- Pages
- 3-25
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W4211260477
- Cited by
- 512
- References
- 2
- FWCI
- 39.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B. https://app.cochat.ai/papers/10.1016/s0168-8278(03)00378-7
- The paper
- Jury, T. E. (2003). EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(03)00378-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
